These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34247311)

  • 1. A Fishy Topic: VITAL, REDUCE-IT, STRENGTH, and Beyond: Putting Omega-3 Fatty Acids into Practice in 2021.
    Iqbal T; Miller M
    Curr Cardiol Rep; 2021 Jul; 23(8):111. PubMed ID: 34247311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eicosapentaenoic acid vs. docosahexaenoic acid for the prevention of cardiovascular disease.
    Sweeney TE; Gaine SP; Michos ED
    Curr Opin Endocrinol Diabetes Obes; 2023 Apr; 30(2):87-93. PubMed ID: 36562280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Disease Risk Reduction in Mild-Moderate Hypertriglyceridemia: Integrating Prescription of Omega-3 with Standard Treatment.
    Picard F; Steg PG
    Curr Atheroscler Rep; 2021 Mar; 23(6):27. PubMed ID: 33788024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues.
    Sherratt SCR; Libby P; Budoff MJ; Bhatt DL; Mason RP
    Curr Atheroscler Rep; 2023 Jan; 25(1):1-17. PubMed ID: 36580204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3-fatty acids: Do they prevent cardiovascular disease?
    Mason RP; Sherratt SCR; Eckel RH
    Best Pract Res Clin Endocrinol Metab; 2023 May; 37(3):101681. PubMed ID: 35739003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS.
    Handelsman Y; Shapiro MD
    Endocr Pract; 2017 Jan; 23(1):100-112. PubMed ID: 27819772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK;
    Circulation; 2019 Sep; 140(12):e673-e691. PubMed ID: 31422671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Clinical Trials Shed New Light on the Cardiovascular Benefits of Omega-3 Fatty Acids.
    Kris-Etherton PM; Richter CK; Bowen KJ; Skulas-Ray AC; Jackson KH; Petersen KS; Harris WS
    Methodist Debakey Cardiovasc J; 2019; 15(3):171-178. PubMed ID: 31687095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do patients benefit from omega-3 fatty acids?
    Sherratt SCR; Mason RP; Libby P; Steg PG; Bhatt DL
    Cardiovasc Res; 2024 Feb; 119(18):2884-2901. PubMed ID: 38252923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hypertriglyceridemia with omega-3 fatty acids].
    Miyoshi T; Ito H
    Nihon Rinsho; 2013 Sep; 71(9):1650-4. PubMed ID: 24205729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 fatty acids and cardiovascular disease: new developments and applications.
    Harris WS; Dayspring TD; Moran TJ
    Postgrad Med; 2013 Nov; 125(6):100-13. PubMed ID: 24200766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options.
    Weintraub H
    Atherosclerosis; 2013 Oct; 230(2):381-9. PubMed ID: 24075771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing Cardiovascular Disease Risk in Women Beyond Statin Therapy: New Insights 2020.
    Mosca L; Navar AM; Wenger NK
    J Womens Health (Larchmt); 2020 Aug; 29(8):1091-1100. PubMed ID: 32297837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the omega-3 fatty acid trial landscape: A narrative review with implications for primary prevention.
    Kapoor K; Alfaddagh A; Stone NJ; Blumenthal RS
    J Clin Lipidol; 2021; 15(4):545-555. PubMed ID: 34294561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega n-3 Supplementation: Exploring the Cardiovascular Benefits Beyond Lipoprotein Reduction.
    Zambon A; Pirillo A; Zambon S; Norata GD; Catapano AL
    Curr Atheroscler Rep; 2020 Oct; 22(12):74. PubMed ID: 33009961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 Fatty Acids in Cardiovascular Disease and Diabetes: a Review of Recent Evidence.
    Bhat S; Sarkar S; Zaffar D; Dandona P; Kalyani RR
    Curr Cardiol Rep; 2023 Feb; 25(2):51-65. PubMed ID: 36729217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 fatty acid therapy for cardiovascular disease: justified or not?
    Maki KC; Dicklin MR
    Curr Opin Cardiol; 2020 Jul; 35(4):417-422. PubMed ID: 32412960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis.
    Quispe R; Alfaddagh A; Kazzi B; Zghyer F; Marvel FA; Blumenthal RS; Sharma G; Martin SS
    Curr Atheroscler Rep; 2022 Jul; 24(7):571-581. PubMed ID: 35499805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icosapent ethyl: drug profile and evidence of reduced residual cardiovascular risk in patients with statin-managed LDL-C cholesterol.
    Bazarbashi N; Miller M
    Expert Rev Cardiovasc Ther; 2020 Apr; 18(4):175-180. PubMed ID: 32228246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 fatty acids for the prevention of atherosclerotic cardiovascular disease.
    Barry AR; Dixon DL
    Pharmacotherapy; 2021 Dec; 41(12):1056-1065. PubMed ID: 34431129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.